Skip to main content
. 2018 Dec 20;13(12):e0209479. doi: 10.1371/journal.pone.0209479

Table 1. Patient characteristics.

Variable of 224 Fraction (%)
Gender Male / Female 196 / 28 87.5 / 12.5
Tumor localization Oral cavity / Oropharynx 51 / 88 22.8 / 39.3
Hypopharynx, Supraglottic larynx 70 / 15 31.2 / 6.7
cT stage 1 / 2 8 / 29 3.6 / 12.9
3 / 4 / Missing 32 / 154 / 1 14.3 / 68.8 / 0.4
cN stage 0 / 1 18 / 11 8.0 / 4.9
2 / 3 164 / 30 73.2 / 13.4
Missing 1 0.5
Grade 1 / 2 6 / 145 2.7 / 64.7
3 / 4 64 / 2 28.6 / 0.9
Missing 7 3.1
WHO 0 / 1 17 / 181 7.6 / 80.8
2 / 3 21 / 5 9.4 / 2.2
Smoking Never / Yes 17 / 170 7.6 / 75.9
Stopped / Missing 29 / 8 12.9 / 3.6
Chemotherapy Yes 123 54.9
No 101 45.1
p53 Negative 108 48.2
Positive 113 50.5
Missing 3 1.3
p16 Negative 180 80.3
Positive 38 17.0
Missing 6 2.7
Variable Median (Range)
Age 58.5 (35.3–91.8)
Delivered dose (Gy) 70.6 (68.0–77.6)
Treatment time (days) 40.5 (36.0–58.0)

Abbreviations: WHO, World Health organization